ARCHIVES

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998